1.0Haavind ENhttps://haavind.no/enHaavind ENhttps://haavind.no/enThe Haavind Pharma Report Summer 2018rich600338<blockquote class="wp-embedded-content" data-secret="l5muPSDPjJ"><a href="https://haavind.no/en/haavind-pharma-report-summer-2018/">The Haavind Pharma Report Summer 2018</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://haavind.no/en/haavind-pharma-report-summer-2018/embed/#?secret=l5muPSDPjJ" width="600" height="338" title="“The Haavind Pharma Report Summer 2018” — Haavind EN" data-secret="l5muPSDPjJ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript">
/* <![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]> */
</script>
We are proud to present the Summer edition of our biannual Pharma Report. The report looks at some of the legal developments during the first half of 2018 in the pharmaceutical sector in Norway.